- Home
- CLPR vs CNTB Comparison
CLPR vs CNTB Comparison
Compare CLPR & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPR
- CNTB
- Stock Information
- Founded
- CLPR 2015
- CNTB 2012
- Country
- CLPR United States
- CNTB United States
- Employees
- CLPR N/A
- CNTB N/A
- Industry
- CLPR Real Estate Investment Trusts
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- CLPR Real Estate
- CNTB Health Care
- Exchange
- CLPR Nasdaq
- CNTB Nasdaq
- Market Cap
- CLPR 63.5M
- CNTB 65.5M
- IPO Year
- CLPR 2017
- CNTB 2021
- Fundamental
- Price
- CLPR $5.11
- CNTB $0.99
- Analyst Decision
- CLPR Sell
- CNTB Strong Buy
- Analyst Count
- CLPR 2
- CNTB 1
- Target Price
- CLPR N/A
- CNTB $8.00
- AVG Volume (30 Days)
- CLPR 108.7K
- CNTB 29.3K
- Earning Date
- CLPR 10-31-2024
- CNTB 09-05-2024
- Dividend Yield
- CLPR 7.36%
- CNTB N/A
- EPS Growth
- CLPR N/A
- CNTB N/A
- EPS
- CLPR N/A
- CNTB N/A
- Revenue
- CLPR $145,595,000.00
- CNTB $24,116,000.00
- Revenue This Year
- CLPR N/A
- CNTB N/A
- Revenue Next Year
- CLPR N/A
- CNTB $63.90
- P/E Ratio
- CLPR N/A
- CNTB N/A
- Revenue Growth
- CLPR 6.78
- CNTB N/A
- 52 Week Low
- CLPR $3.38
- CNTB $0.68
- 52 Week High
- CLPR $7.12
- CNTB $2.66
- Technical
- Relative Strength Index (RSI)
- CLPR 34.82
- CNTB 39.75
- Support Level
- CLPR $5.01
- CNTB $0.91
- Resistance Level
- CLPR $6.40
- CNTB $1.09
- Average True Range (ATR)
- CLPR 0.24
- CNTB 0.11
- MACD
- CLPR -0.12
- CNTB -0.01
- Stochastic Oscillator
- CLPR 7.19
- CNTB 16.18
About CLPR Clipper Realty Inc.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. Clipper derives its revenue mostly from a Residential segment.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.